Management of Sexually Transmitted Diseases in HIV-Infected Men and Women

  • Author: Jeanne Marrazzo, MD, MPH, FACP, FIDSA (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/8/18 (What's New)

Summary

  • The quadrivalent human papillomavirus vaccine confers protection against HPV types 6/11 (responsible for 90% of genital warts) and 16/18 (responsible for 70% of cervical cancers)[Markowitz 2007]
    • The quadrivalent vaccine is also approved by the FDA for prevention of anal cancer and associated precancerous lesions in persons infected with these HPV types[FDA 2010]
  • The 9-valent human papillomavirus vaccine confers protection against HPV subtypes 6, 11, 16, 18, 31, 33, 45, 52, and 58

    Action required

    Keywords: HPV, Sexually Transmitted Diseases, Women

    ©2020 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.